TFF PHARMACEUTICALS, INC. Other Research and Development Expense
TFF PHARMACEUTICALS, INC. reported Other Research and Development Expense of $121.71 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherResearchAndDevelopmentExpense · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. other research and development expense for the quarter ending 2024-09-30 was $121.71K, a 36.83% increase year-over-year.
- TFF PHARMACEUTICALS, INC. other research and development expense for the quarter ending 2024-06-30 was $103.93K, a 7.63% increase year-over-year.
- TFF PHARMACEUTICALS, INC. other research and development expense for the quarter ending 2024-03-31 was $122.40K, a 391.44% increase year-over-year.
- TFF PHARMACEUTICALS, INC. other research and development expense for the quarter ending 2023-09-30 was $88.95K.
- TFF PHARMACEUTICALS, INC. other research and development expense for fiscal 2021 was $536.00K.
- TFF PHARMACEUTICALS, INC. other research and development expense for fiscal 2019 was $1.13M.
USD
| Period end | Other Research and Development Expense 3 month | Other Research and Development Expense 3 month as first filed | Other Research and Development Expense 6 month | Other Research and Development Expense 6 month as first filed | Other Research and Development Expense 9 month | Other Research and Development Expense 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | $121.71K 10-Q · filed 2024-11-20 | $225.64K derived: sum of 2 quarters · filed 2024-11-20 | $347.97K 10-Q · filed 2024-11-20 | |||
| 2024-06-30 | $103.93K 10-Q · filed 2024-08-14 | $226.34K 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | $122.40K 10-Q · filed 2024-05-14 | |||||
| 2023-09-30 | $88.95K 10-Q · filed 2024-11-20 | $185.51K derived: sum of 2 quarters · filed 2024-11-20 | $211.78K 10-Q · filed 2024-11-20 | |||
| 2023-06-30 | $96.56K 10-Q · filed 2024-08-14 | $122.27K 10-Q · filed 2024-08-14 | ||||
| 2023-03-31 | $24.91K 10-Q · filed 2024-05-14 | $188.77K 10-Q · filed 2023-05-11 | ||||
| 2022-12-31 | $186.51K 10-Q · filed 2023-05-11 | |||||
| 2022-06-30 | $28.83K 10-Q · filed 2022-08-11 | $144.67K 10-Q · filed 2022-08-11 | -$723.29K derived: sum of 3 quarters · filed 2023-05-11 | -$84.29K derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2022-03-31 | $147.88K 10-Q · filed 2023-05-11 | -$752.12K derived: sum of 2 quarters · filed 2023-05-11 | -$113.12K derived: sum of 3 quarters · filed 2023-05-11 | $403.29K derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$261.00K derived: sum of 2 quarters · filed 2023-03-31 | $255.41K derived: sum of 3 quarters · filed 2023-03-31 | $536.00K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $639.00K 10-Q · filed 2021-11-15 | $1.16M derived: sum of 2 quarters · filed 2022-08-11 | $1.44M 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $516.41K 10-Q · filed 2022-08-11 | $303.00K 10-Q · filed 2021-08-12 | $516.41K 10-Q · filed 2022-08-11 | $797.00K 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | $494.00K 10-Q · filed 2021-05-13 | |||||
| 2020-09-30 | $249.00K 10-Q · filed 2021-11-15 | $931.00K derived: sum of 2 quarters · filed 2021-11-15 | $1.27M 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $682.00K 10-Q · filed 2021-08-12 | $1.02M 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | $341.00K 10-Q · filed 2021-05-13 | |||||
| 2019-12-31 | $1.13M 10-K · filed 2022-03-24 |
AUD
| Period end | Other Research and Development Expense 12 month |
|---|---|
| 2022-12-31 | 714.00K AUD 10-K · filed 2023-03-31 |